West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
316.59
-4.29 (-1.34%)
Nov 22, 2024, 4:00 PM EST - Market closed
WST Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 499.6 | 593.4 | 585.9 | 661.8 | 346.2 | 241.7 | Upgrade
|
| Depreciation & Amortization | 150.6 | 137.3 | 120.6 | 122.3 | 109.1 | 103.4 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 11.6 | - | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.6 | 9.6 | 21.5 | 5.6 | 7.7 | 3.1 | Upgrade
|
| Loss (Gain) on Equity Investments | -14.3 | -14.3 | -18.1 | -17.4 | -15.8 | -6.7 | Upgrade
|
| Stock-Based Compensation | 15.8 | 23.3 | 23.7 | 37.5 | 34 | 24.4 | Upgrade
|
| Other Operating Activities | 39.8 | 36 | 5.4 | -27.7 | 1.6 | 15.7 | Upgrade
|
| Change in Accounts Receivable | 4 | 4 | -35.6 | -123.5 | -46.6 | -33.3 | Upgrade
|
| Change in Inventory | -13.5 | -13.5 | -49.8 | -86.5 | -73.7 | -18.6 | Upgrade
|
| Change in Accounts Payable | 4.4 | 4.4 | -2.8 | 16.8 | 36.6 | 25.3 | Upgrade
|
| Change in Other Net Operating Assets | 11.4 | -15.3 | 73.2 | -4.9 | 73.4 | 12.2 | Upgrade
|
| Operating Cash Flow | 702.4 | 776.5 | 724 | 584 | 472.5 | 367.2 | Upgrade
|
| Operating Cash Flow Growth | -8.57% | 7.25% | 23.97% | 23.60% | 28.68% | 27.23% | Upgrade
|
| Capital Expenditures | -380.8 | -362 | -284.6 | -253.4 | -174.4 | -126.4 | Upgrade
|
| Cash Acquisitions | - | - | - | -2.2 | - | -18.9 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -85.1 | Upgrade
|
| Other Investing Activities | -1.9 | -6.7 | -3.6 | 2.5 | -5.1 | 2.4 | Upgrade
|
| Investing Cash Flow | -382.7 | -368.7 | -288.2 | -253.1 | -179.5 | -228 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 198.5 | Upgrade
|
| Total Debt Issued | 164.7 | - | - | - | - | 198.5 | Upgrade
|
| Long-Term Debt Repaid | - | -2.3 | -44.3 | -2.2 | -2.3 | -136.4 | Upgrade
|
| Total Debt Repaid | -192.8 | -2.3 | -44.3 | -2.2 | -2.3 | -136.4 | Upgrade
|
| Net Debt Issued (Repaid) | -28.1 | -2.3 | -44.3 | -2.2 | -2.3 | 62.1 | Upgrade
|
| Issuance of Common Stock | 32.7 | 51 | 28.2 | 37.1 | 34.7 | 32.7 | Upgrade
|
| Repurchase of Common Stock | -689.1 | -451.2 | -222.2 | -151.9 | -121.4 | -85.3 | Upgrade
|
| Common Dividends Paid | -58.6 | -57 | -54.1 | -51.1 | -48.1 | -45.1 | Upgrade
|
| Other Financing Activities | -0.1 | -0.1 | -1.2 | - | - | -1.2 | Upgrade
|
| Financing Cash Flow | -743.2 | -459.6 | -293.6 | -168.1 | -137.1 | -36.8 | Upgrade
|
| Foreign Exchange Rate Adjustments | 15.8 | 11.4 | -10.5 | -15.7 | 20.5 | -0.7 | Upgrade
|
| Net Cash Flow | -407.7 | -40.4 | 131.7 | 147.1 | 176.4 | 101.7 | Upgrade
|
| Free Cash Flow | 321.6 | 414.5 | 439.4 | 330.6 | 298.1 | 240.8 | Upgrade
|
| Free Cash Flow Growth | -23.43% | -5.67% | 32.91% | 10.90% | 23.80% | 30.94% | Upgrade
|
| Free Cash Flow Margin | 11.18% | 14.05% | 15.22% | 11.68% | 13.89% | 13.09% | Upgrade
|
| Free Cash Flow Per Share | 4.34 | 5.50 | 5.80 | 4.33 | 3.93 | 3.19 | Upgrade
|
| Cash Interest Paid | 6 | 6 | 6.6 | 8 | 8.1 | 8.6 | Upgrade
|
| Cash Income Tax Paid | 90.8 | 90.8 | 109.7 | 171.8 | 48.4 | 47.5 | Upgrade
|
| Levered Free Cash Flow | 201.69 | 199.04 | 248.73 | 212.74 | 250.4 | 164.59 | Upgrade
|
| Unlevered Free Cash Flow | 204.81 | 204.66 | 253.66 | 217.86 | 255.53 | 169.9 | Upgrade
|
| Change in Net Working Capital | -47.9 | 38 | 85.6 | 171.6 | -22.7 | 16.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.